Team Leidos, trading through “Leidos Supply Limited”, and acting as Agent on behalf of the MoD, would like to make interested suppliers aware that it intends to tender its Medical Pharmaceutical requirement in 2021, with a view to awarding one or more Contracts that will commence during 2021 for a period of up to 4 years.
This includes: Pharmaceutical products. Pharmaceutical articles. Medicinal products for the alimentary tract and metabolism. Medicinal products for the blood, blood-forming organs and the cardiovascular system. Medicinal products for dermatology and the musculoskeletal system. Medicinal products for the genitourinary system and hormones. General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents. Medicinal products for the nervous system and sensory organs. Medicinal products for the respiratory system. Various medicinal products. Stomatology devices. Sun protection products. The supply, delivery and dispensing of Medical Pharmaceutical products, to include stoma & ostomy products, haematological consumables and provision of pre packed over labelling & break down of bulk packs service.
This Prior Information Notice is not a means to submit a formal expression of interest in respect of any potential tender. Any resultant requirement will be subject to the UK Public Procurement Regulations and respective advertising action.
The estimated 4 year value is Â£41,600,000 – Â£115,000,000.